Prediction of optimal versus suboptimal cytoreduction of advanced-stage serious ovarian cancer with the use of microarrays

Author：  

Publisher： Informa Healthcare

ISSN： 1473-3404

Source： The Women's Oncology Review, Vol.4, Iss.3, 2004-09, pp. : 203-204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Prognostic Implication of Ascites in Advanced-Stage Ovarian Cancer

By Puls L.E.   Duniho T.   Hunter IV J.E.   Kryscio R.   Blackhurst D.   Gallion H.  

Gynecologic Oncology, Vol. 61, Iss. 1, 1996-04 ,pp. : 109-112

Academic Press

Access to resources Recommend Favorite

A Critique of Surgical Cytoreduction in Advanced Ovarian Cancer

By Covens A.L.  

Gynecologic Oncology, Vol. 78, Iss. 3, 2000-09 ,pp. : 269-274

Elsevier

Access to resources Recommend Favorite

Preoperative Prediction of Optimal Resectability in Advanced Ovarian Cancer Using CA-125

By Berek J.S.  

Gynecologic Oncology, Vol. 77, Iss. 2, 2000-05 ,pp. : 225-226

Elsevier

Access to resources Recommend Favorite

Survival Impact of Surgical Cytoreduction in Stage IV Epithelial Ovarian Cancer

By Bristow R.E.   Montz F.J.   Lagasse L.D.   Leuchter R.S.   Karlan B.Y.  

Gynecologic Oncology, Vol. 72, Iss. 3, 1999-03 ,pp. : 278-287

Elsevier

Access to resources Recommend Favorite

Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer

By Mazzeo F.   Berliere M.   Kerger J.   Squifflet J.   Duck L.   D'Hondt V.   Humblet Y.   Donnez J.   Machiels J.-P.  

Gynecologic Oncology, Vol. 90, Iss. 1, 2003-07 ,pp. : 163-169

Elsevier

Access to resources Recommend Favorite